Jeri Ann Boose

home / authors / jeri-ann-boose

Articles

Part 6: Inactivation Methods Grouped by Virus

Gail Sofer;Jeri Ann Boose;Dorothy C. Lister

June 1st 2003

by Gail Sofer, BioReliance, Dorothy C. Lister, and Jeri Ann Boose

Virus Inactivation in the 1990s and into the 21st Century

Gail Sofer;Jeri Ann Boose;Dorothy C. Lister

April 15th 2003

by Gail Sofer, BioReliance Dorothy C. Lister, and Jeri Ann Boose Smallest of the microorganisms, viruses depend on other cells ? like those used by biopharmaceutical manufacturers ? for reproduction. And viruses and drug products are idiosyncratic: Both the inactivation process and the product strongly influence the successful outcome. In this conclusion to the virus inactivation series, model ivruses are used to represent single- and double-stranded DNA and RNA viruses, to enable you to reach conclusions about effective inactivation methods for a range of viruses.

Retrovirus and Parvovirus Clearance from an Affinity Column Product Using Adsorptive Depth Filtration

William Larsen;Jeri Ann Boose;Joanne Beck;Barbara Tipton;Thomas O'Brien

September 15th 2002

by Barbara Tipton, Jeri Ann Boose, Joanne Beck, Thomas O'Brien, and William Larsen, CUNO Incorporated Two types of depth filters are studied for their ability to rid protein solutions of retroviruses and parvoviruses. Such filters are relatively economical and easy to use, so as secondary virus-removing devices, they are beneficial for downstream processing of mammalian cell cultures. Results indicate that depth filters are more effective on retroviruses than parvoviruses.